Single-cell analysis of bronchoalveolar cells in inflammatory and fibrotic post-COVID lung disease

Front Immunol. 2024 May 17:15:1372658. doi: 10.3389/fimmu.2024.1372658. eCollection 2024.

Abstract

Background: Persistent radiological lung abnormalities are evident in many survivors of acute coronavirus disease 2019 (COVID-19). Consolidation and ground glass opacities are interpreted to indicate subacute inflammation whereas reticulation is thought to reflect fibrosis. We sought to identify differences at molecular and cellular level, in the local immunopathology of post-COVID inflammation and fibrosis.

Methods: We compared single-cell transcriptomic profiles and T cell receptor (TCR) repertoires of bronchoalveolar cells obtained from convalescent individuals with each radiological pattern, targeting lung segments affected by the predominant abnormality.

Results: CD4 central memory T cells and CD8 effector memory T cells were significantly more abundant in those with inflammatory radiology. Clustering of similar TCRs from multiple donors was a striking feature of both phenotypes, consistent with tissue localised antigen-specific immune responses. There was no enrichment for known SARS-CoV-2-reactive TCRs, raising the possibility of T cell-mediated immunopathology driven by failure in immune self-tolerance.

Conclusions: Post-COVID radiological inflammation and fibrosis show evidence of shared antigen-specific T cell responses, suggesting a role for therapies targeting T cells in limiting post-COVID lung damage.

Keywords: COVID-19; SARS-CoV-2; T cell receptor; fibrosis; inflammation; scRNAseq.

MeSH terms

  • Adult
  • Aged
  • Bronchoalveolar Lavage Fluid / cytology
  • Bronchoalveolar Lavage Fluid / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • COVID-19* / immunology
  • COVID-19* / pathology
  • Female
  • Humans
  • Inflammation / immunology
  • Inflammation / pathology
  • Lung / diagnostic imaging
  • Lung / immunology
  • Lung / pathology
  • Male
  • Memory T Cells / immunology
  • Middle Aged
  • Pulmonary Fibrosis / etiology
  • Pulmonary Fibrosis / immunology
  • Pulmonary Fibrosis / pathology
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Antigen, T-Cell / immunology
  • Receptors, Antigen, T-Cell / metabolism
  • SARS-CoV-2* / immunology
  • Single-Cell Analysis*
  • Transcriptome

Substances

  • Receptors, Antigen, T-Cell

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. PM is supported by a Medical Research Council (MRC)/GlaxoSmithKline Experimental Medicine Initiative to Explore New Therapies network (EMINENT) Clinical Research Training Fellowship. ED is supported by Breathing Matters. MZN is supported by a UK MRC Clinician Scientist Fellowship (MR/W00111X/1) and a Rutherford Fund Fellowship allocated by the MRC UK Regenerative Medicine Platform 2 (MR/S005579/1). MN is supported by the Wellcome Trust (207511/Z/17/Z). GST is supported by a UK MRC Clinician Scientist Fellowship (MR/N007727/1). PM, ED, MP, JB, MZN, MN, RC, JP and GT are also supported by NIHR Biomedical Research Funding to UCL and UCLH.